Cyclooxygenase-3 (COX-3): filling in the gaps toward a COX continuum?
作者信息
Warner Timothy D, Mitchell Jane A
机构信息
The William Harvey Research Institute, Bart's and the London School of Medicine and Dentistry, Charterhouse Square, London EC1M 6BQ, United Kingdom.
出版信息
Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13371-3. doi: 10.1073/pnas.222543099. Epub 2002 Oct 8.
Abstract
摘要
相似文献
1
Cyclooxygenase-3 (COX-3): filling in the gaps toward a COX continuum?
Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13371-3. doi: 10.1073/pnas.222543099. Epub 2002 Oct 8.
2
The discovery and function of COX-2.
J Rheumatol Suppl. 1997 Jul;49:6-8.
3
COX-2 inhibitors--is there cause for concern?
Nat Med. 1999 Jun;5(6):621-2. doi: 10.1038/9465.
4
Cox-2-selective inhibitors: the new super aspirins.
Mol Pharmacol. 1999 Apr;55(4):625-31.
5
[New NSAIDS: COX-1, COX-2, what about them?].
Rev Med Brux. 1998 Sep;19(4):A399-402.
6
COX-1 and COX-2 inhibition: current status and future perspective.
Acta Anaesthesiol Belg. 1998;49(3):175-83.
7
The future of NSAID therapy: selective COX-2 inhibitors.
Int J Clin Pract. 2000 Jan-Feb;54(1):7-9.
8
[COX-1 and COX-2: functions and pharmacological effects].
Pharm Unserer Zeit. 1999 Jan;28(1):21-9.
9
[In vivo selectivity of nonsteroidal anti-inflammatory drugs on COX-1-COX-2 and gastrointestinal ulcers, in rats].
Acta Gastroenterol Latinoam. 1998;28(3):249-55.
10
[Biological functions of cyclooxygenase 2: control of its expression and activity].
J Soc Biol. 2000;194(3-4):189-93.
引用本文的文献
1
NSAID-encapsulated nanoparticles as a targeted therapeutic platform for modulating chronic inflammation and inhibiting cancer progression: a review.
Inflammopharmacology. 2025 Apr 26. doi: 10.1007/s10787-025-01760-8.
2
Effectiveness of long-term low-dose aspirin in the prevention of gastric cancer after Helicobacter pylori eradication: study design and rationale of Ardabil gastric cancer randomized placebo-controlled prevention trial (AGCPT).
Trials. 2024 Sep 19;25(1):617. doi: 10.1186/s13063-024-08455-5.
3
A Narrative Review of the Published Pre-Clinical Evaluations: Multiple Effects of Arachidonic Acid, its Metabolic Enzymes and Metabolites in Epilepsy.
Mol Neurobiol. 2025 Jan;62(1):288-303. doi: 10.1007/s12035-024-04274-6. Epub 2024 Jun 6.
4
Analgesic Efficacy of Non-Steroidal Anti-Inflammatory Drug Therapy in Horses with Abdominal Pain: A Systematic Review.
Animals (Basel). 2023 Nov 8;13(22):3447. doi: 10.3390/ani13223447.
5
A Spontaneous Spinal Epidural Hematoma Secondary to Long-Term Low-Dose Aspirin and Clopidogrel Use: A Case Report.
Cureus. 2023 Feb 2;15(2):e34537. doi: 10.7759/cureus.34537. eCollection 2023 Feb.
6
Rhenium(V) Complexes as Cysteine-Targeting Coordinate Covalent Warheads.
J Med Chem. 2023 Feb 23;66(4):3088-3105. doi: 10.1021/acs.jmedchem.2c02074. Epub 2023 Feb 8.
7
Perspectives of the Application of Non-Steroidal Anti-Inflammatory Drugs in Cancer Therapy: Attempts to Overcome Their Unfavorable Side Effects.
Cancers (Basel). 2023 Jan 12;15(2):475. doi: 10.3390/cancers15020475.
8
Acetylsalicylic Acid-Primus Inter Pares in Pharmacology.
Molecules. 2022 Dec 1;27(23):8412. doi: 10.3390/molecules27238412.
9
Applications of covalent chemistry in targeted protein degradation.
Chem Soc Rev. 2022 Nov 14;51(22):9243-9261. doi: 10.1039/d2cs00362g.
10
Cyclooxygenase-2 immunohistochemical expression is associated with worse prognosis in breast cancer: Retrospective study and literature review.
Saudi Med J. 2022 Jul;43(7):687-693. doi: 10.15537/smj.2022.43.7.20220052.
本文引用的文献
1
COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression.
Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13926-31. doi: 10.1073/pnas.162468699. Epub 2002 Sep 19.
2
Peripheral prostanoid levels and nonsteroidal anti-inflammatory drug analgesia: replicate clinical trials in a tissue injury model.
Clin Pharmacol Ther. 2002 Aug;72(2):175-83. doi: 10.1067/mcp.2002.126501.
3
Comparison of the analgesic efficacy of rofecoxib and enteric-coated diclofenac sodium in the treatment of postoperative dental pain: a randomized, placebo-controlled clinical trial.
Clin Ther. 2002 Apr;24(4):490-503. doi: 10.1016/s0149-2918(02)85126-8.
4
Determinants of the cellular specificity of acetaminophen as an inhibitor of prostaglandin H(2) synthases.
Proc Natl Acad Sci U S A. 2002 May 14;99(10):7130-5. doi: 10.1073/pnas.102588199.
5
Up-regulation of COX-2 by inhibition of COX-1 in the rat: a key to NSAID-induced gastric injury.
Aliment Pharmacol Ther. 2002 Apr;16 Suppl 2:90-101. doi: 10.1046/j.1365-2036.16.s2.22.x.
6
Pharmacology of cyclooxygenase-2 inhibition in the kidney.
Kidney Int. 2002 Apr;61(4):1210-9. doi: 10.1046/j.1523-1755.2002.00263.x.
7
Cardiovascular pharmacology of nonselective nonsteroidal anti-inflammatory drugs and coxibs: clinical considerations.
Am J Cardiol. 2002 Mar 21;89(6A):26D-32D. doi: 10.1016/s0002-9149(02)02234-8.
8
Cyclooxygenase-2: a therapeutic target.
Annu Rev Med. 2002;53:35-57. doi: 10.1146/annurev.med.53.082901.103952.
9
The spinal phospholipase-cyclooxygenase-prostanoid cascade in nociceptive processing.
Annu Rev Pharmacol Toxicol. 2002;42:553-83. doi: 10.1146/annurev.pharmtox.42.092401.143905.
10
Valdecoxib, a COX-2-specific inhibitor, is an efficacious, opioid-sparing analgesic in patients undergoing hip arthroplasty.
Am J Ther. 2002 Jan-Feb;9(1):43-51. doi: 10.1097/00045391-200201000-00009.
Zotero 插件